{"title":"Network-based pharmacology to predict the mechanism of qianghuo erhuang decoction in the treatment of rheumatoid arthritis.","authors":"Xuemeng Chen, Qinghua Zou, Bing Zhong, Yong Wang","doi":"10.4314/ahs.v24i4.37","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To investigate the mechanisms of Qianghuo Erhuang Decoction (QED) in the treatment of rheumatoid arthritis (RA), we performed compounds, targets prediction and network analysis using a network pharmacology method.</p><p><strong>Methodology: </strong>We collected active ingredients and targets of QED according to the database of Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP) and selected therapeutic targets on RA. \"drug-ingredient-target\" network was made for the intersecting genes. The STRING database was used for constructing a protein-protein interaction network (PPI) for the intersection genes, and R version 4.1.2 software was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis.</p><p><strong>Results: </strong>We found that there were 141 main active ingredients in QED, of which the main core active ingredients were: β-sitosterol, stigmasterol, baicalein, wogonin, kaempferol, etc., involving 166 RA genes. GO enrichment analysis results showed that QED involved 2229 biological processes, 78 cell components and 212 molecular functions. QED might interfere and treat RA through lipid and atherosclerosis, cancer pathways, PI3K-Akt, AGE-RAGE, IL-17, TNF, as well as HIF-1 signaling pathways.</p><p><strong>Conclusions: </strong>QED may treat RA by regulating inflammation-related signaling pathways, angiogenesis signaling pathways, and reducing the expression of inflammatory factors.</p>","PeriodicalId":94295,"journal":{"name":"African health sciences","volume":"24 4","pages":"286-298"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970153/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African health sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/ahs.v24i4.37","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To investigate the mechanisms of Qianghuo Erhuang Decoction (QED) in the treatment of rheumatoid arthritis (RA), we performed compounds, targets prediction and network analysis using a network pharmacology method.
Methodology: We collected active ingredients and targets of QED according to the database of Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP) and selected therapeutic targets on RA. "drug-ingredient-target" network was made for the intersecting genes. The STRING database was used for constructing a protein-protein interaction network (PPI) for the intersection genes, and R version 4.1.2 software was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis.
Results: We found that there were 141 main active ingredients in QED, of which the main core active ingredients were: β-sitosterol, stigmasterol, baicalein, wogonin, kaempferol, etc., involving 166 RA genes. GO enrichment analysis results showed that QED involved 2229 biological processes, 78 cell components and 212 molecular functions. QED might interfere and treat RA through lipid and atherosclerosis, cancer pathways, PI3K-Akt, AGE-RAGE, IL-17, TNF, as well as HIF-1 signaling pathways.
Conclusions: QED may treat RA by regulating inflammation-related signaling pathways, angiogenesis signaling pathways, and reducing the expression of inflammatory factors.
背景:为探讨强火二黄汤(QED)治疗类风湿关节炎(RA)的作用机制,采用网络药理学方法进行化合物、靶点预测和网络分析。方法:根据中药系统药理学数据库与分析平台(TCMSP)数据库收集QED的有效成分和靶点,筛选出治疗类风湿性关节炎的靶点。交叉基因构建“药物-成分-靶点”网络。使用STRING数据库构建交叉基因的蛋白-蛋白互作网络(PPI),使用R version 4.1.2软件进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析。结果:我们发现QED中有141种主要活性成分,其中主要核心活性成分为:β-谷甾醇、豆甾醇、黄芩素、木犀草素、山奈酚等,涉及166个RA基因。氧化石墨烯富集分析结果表明,QED涉及2229个生物过程、78个细胞组分和212个分子功能。QED可能通过脂质和动脉粥样硬化、癌症通路、PI3K-Akt、AGE-RAGE、IL-17、TNF以及HIF-1信号通路干预和治疗RA。结论:QED可能通过调节炎症相关信号通路、血管生成信号通路、降低炎症因子表达来治疗RA。